We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-0.16%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$12.7B
AUM Growth
+$566M
Cap. Flow
+$690M
Cap. Flow %
5.42%
Top 10 Hldgs %
16.23%
Holding
2,054
New
761
Increased
358
Reduced
482
Closed
414

Sector Composition

Rank Sector Weight
1 Healthcare 25.14%
2 Consumer Discretionary 19.28%
3 Technology 12.46%
4 Industrials 8.42%
5 Financials 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALNT icon
1551
Allient
ALNT
$1.47B
$32K ﹤0.01%
+1,353
New +$33K
PLUR icon
1552
Pluri
PLUR
$19.2M
$32K ﹤0.01%
+987
New +$36.3K
PSEC icon
1553
Prospect Capital
PSEC
$1.06B
$32K ﹤0.01%
4,911
-289,870
-98% -$1.91M
SVC
1554
Service Properties Trust
SVC
$1.1B
$32K ﹤0.01%
+245
New +$30.3K
XELB icon
1555
Xcel Brands
XELB
$7.45M
$32K ﹤0.01%
+1,671
New +$34K
DXPE icon
1556
DXP Enterprises
DXPE
$2.62B
$31K ﹤0.01%
+903
New +$30.3K
HIW icon
1557
Highwoods Properties
HIW
$3.71B
$31K ﹤0.01%
+700
New +$30.7K
KOPN icon
1558
Kopin
KOPN
$663M
$31K ﹤0.01%
+45,138
New +$45.1K
OII icon
1559
Oceaneering
OII
$5.25B
$31K ﹤0.01%
+2,318
New +$35.1K
VBK icon
1560
Vanguard Small-Cap Growth ETF
VBK
$23.2B
$31K ﹤0.01%
+171
New +$31.8K
DMK
1561
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$31K ﹤0.01%
+634
New +$45.5K
AMRX icon
1562
Amneal Pharmaceuticals
AMRX
$5.72B
$30K ﹤0.01%
+10,479
New +$36.6K
LITS
1563
Lite Strategy Inc
LITS
$33.6M
$30K ﹤0.01%
+896
New +$32.6K
TUR icon
1564
iShares MSCI Turkey ETF
TUR
$206M
$30K ﹤0.01%
1,143
-54,834
-98% -$1.38M
WASH icon
1565
Washington Trust Bancorp
WASH
$732M
$30K ﹤0.01%
+618
New +$30.2K
WLKP icon
1566
Westlake Chemical Partners
WLKP
$777M
$30K ﹤0.01%
+1,299
New +$29.4K
CASH icon
1567
Pathward Financial
CASH
$1.81B
$29K ﹤0.01%
+899
New +$27.1K
CRMD icon
1568
CorMedix
CRMD
$617M
$29K ﹤0.01%
+4,552
New +$38.3K
ESNT icon
1569
Essent Group
ESNT
$6.06B
$29K ﹤0.01%
+598
New +$28.6K
HTH icon
1570
Hilltop Holdings
HTH
$2.29B
$29K ﹤0.01%
+1,208
New +$27.7K
URGN icon
1571
UroGen Pharma
URGN
$2B
$29K ﹤0.01%
+1,219
New +$39.9K
YMAB
1572
DELISTED
Y-mAbs Therapeutics
YMAB
$29K ﹤0.01%
+1,100
New +$28.1K
KDNY
1573
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$29K ﹤0.01%
+5,507
New +$36.6K
EVOP
1574
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$29K ﹤0.01%
1,030
-57,630
-98% -$1.69M
QHC
1575
DELISTED
Quorum Health Corporation
QHC
$29K ﹤0.01%
+24,000
New +$32.4K

Similar funds

Marshall Wace's Q3 2019 Portfolio in Review

As of Q3 2019, Marshall Wace held 2,054 positions worth $12.7B, up 4.7% from $12.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace deployed $690M of net new capital in Q3 2019, opening 761 new positions and adding to 358 existing holdings. Its largest new stake was Restaurant Brands International: 1,898,808 shares worth $135M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Amazon, an estimated $141M trimmed.

  • Marshall Wace's largest Q3 2019 buy was Restaurant Brands International: 1,898,808 shares worth $135M.
  • Marshall Wace added most to Danaher in Q3 2019, an estimated $74.1M increase.
  • Marshall Wace's biggest Q3 2019 reduction was Amazon, cutting an estimated $141M.
  • Marshall Wace fully exited Red Hat Inc in Q3 2019, selling an estimated $53.6M.
  • Marshall Wace's ten largest holdings make up 16% of its $12.7B portfolio in Q3 2019.
  • Marshall Wace opened 761 new positions and closed 414 in Q3 2019.
  • Marshall Wace's portfolio value rose 4.7% quarter-over-quarter to $12.7B.

Based on Marshall Wace's 13F filing for Q3 2019, filed 14 Nov 2019.